PharmaCyte Biotech Inc — Liquidità (NASDAQ:PMCB)

Financials

Flusso di cassa derivante dalle attività operative -3.33 M-4.12 M-3.79 M-2.15 M-2.98 M -4.8 M Flussi di cassa derivanti dalle attività di investimento 000-5 M-7 M 2 M Liquidità derivante dalle attività di finanziamento 4.64 M87.31 M-13.56 M-10.71 M-25.03 M 6.58 M Liquidità libera -3.33 M-4.12 M-3.79 M-2.15 M-2.98 M -4.8 M

PMCB

Financials

Notizie

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232

Pharmacyte Biotech CEO Silverman buys $80k in shares

Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Autodesk (NASDAQ:ADSK), Ambarella (NASDAQ:AMBA)

Il titolo di PharmaCyte Biotech vola dopo la vendita della quota in Femasys

PharmaCyte Biotech stock soars after successful Femasys stake sale

PharmaCyte Biotech closes $7 million financing to strengthen position

PharmaCyte Biotech secures $7 million in private placement financing